Tuberculosis News and Research

Latest Tuberculosis News and Research

Aeras Global receives FDA grant to develop biomarkers for TB vaccine

The Aeras Global TB Vaccine Foundation is pleased to announce receipt of a grant from the United States Food and Drug Administration (FDA) to develop new biological and immunological biomarkers for TB vaccine development. The FDA grant, which supports the coordination of a multi-investigator project with researchers from the United States, the United Kingdom and South Africa, will provide $362,102 in the first year of funding.

5 Oct 2010

FDA awards $2.9 million to support tuberculosis research projects

The U.S. Food and Drug Administration today announced the award of $2.9 million to support six research projects that will help with the diagnosis, treatment, and prevention of tuberculosis (TB).

5 Oct 2010

Media outlets look ahead to next week's Global Fund replenishment meeting

Ahead of next week's replenishment meeting of the Global Fund to Fight AIDS, Tuberculosis and Malaria in New York, IRIN/PlusNews examines the challenges associated with trying to ramp up programs worldwide to meet global health targets.

4 Oct 2010

Scientist discovers novel pathogen from Mycobacterium tuberculosis complex

Kathleen Alexander, associate professor of wildlife in Virginia Tech's College of Natural Resources and Environment, has discovered a novel tuberculosis (TB) species in the Mycobacterium tuberculosis complex, a group of pathogens that have adapted by using mammals as hosts. It has been nearly two decades since a new organism was identified in this group; the majority were discovered in the early and mid 20th century.

3 Oct 2010

GSA urges treatment of sepsis as a medical emergency

The Global Sepsis Alliance (GSA) is urging healthcare providers, patients and policymakers worldwide to treat sepsis as a medical emergency. "Tens of millions of people die from sepsis each year, making it the likely leading cause of death worldwide. Sepsis kills regardless of age, ethnicity, location and access to care," said Konrad Reinhart, M.D., Chairman of the GSA and director of the Department of Anesthesiology and Intensive Care Medicine, University Hospital of the Friedrich Schiller, University of Jena, Germany.

1 Oct 2010

FDA grants Emergent Fast Track Designation for AVP-21D9 anthrax monoclonal antibody development program

Emergent BioSolutions Inc. announced today that its anthrax monoclonal antibody development program investigating AVP-21D9 for the treatment of inhalational anthrax has been granted Fast Track Designation by the U.S. Food and Drug Administration (FDA). Emergent recently commenced a Phase I clinical trial for AVP-21D9, which is a fully human monoclonal antibody product candidate being developed as a parenteral post-exposure therapeutic to treat symptoms of inhalational anthrax disease.

1 Oct 2010

U.N. agencies' report examines global progress in fight against HIV/AIDS

"A record 1.2 million people in low- and middle-income countries started antiretroviral therapy for HIV/AIDS in 2009" - a 30 percent increase from the previous year and a 13-fold increase in six years, according to a joint report released Tuesday by the WHO, UNICEF and UNAIDS, Reuters reports. In total, the report found that 5.25 million people received antiretroviral therapy (ART) in 2009, three-quarters of them living in Africa (Migiro, 9/28).

30 Sep 2010

Opinions: U.S. aid to Pakistan; MDGS; GHI and Global Fund

The U.S. military has been working hard to provide flood assistance, but most of that is invisible to Pakistanis, David Ignatius writes in a Washington Post opinion piece. The article examines the views of Pakistani flood victims, including criticism of their own government's response.

30 Sep 2010

Significant progress made universally in increasing access to HIV/AIDS services: Report

Significant progress has been made in several low- and middle-income countries in increasing access to HIV/AIDS services, according to a new report released today. The report Towards universal access by WHO, the United Nations Children's Fund and the Joint United Nations Programme on HIV/AIDS is the fourth annual report for tracking progress made in achieving the 2010 target of providing universal access to HIV prevention, treatment and care.

29 Sep 2010

Tamir's compounds perform better than Ganciclovir for Cytomegalovirus disease: Study

Tamir Biotechnology, Inc. announced today that scientists supported by the National Institute of Allergy and Infectious Diseases (NIAID) reported test results confirming two of our lead compounds outperformed market leader Roche's drug Ganciclovir in cell culture and plaque reduction assay (the gold standard) for Cytomegalovirus (CMV) disease. Additionally, antiviral activity was also apparent against other human herpesviruses, namely, HSV-1 (cold sores), HSV-2 (genital herpes), and Varicella-Zoster Virus (VZV) (chicken-pox and shingles).

29 Sep 2010

NIH grants Akonni $3M for development of multi-drug resistant/extensively drug-resistant genotyping test

Akonni Biosystems, a molecular diagnostics company that develops, manufactures, and plans to market sophisticated genetic testing devices for complex infectious and human diseases, today announced receipt of a nearly $3 million Challenge Grant from the National Institutes of Health (NIH), a new program made possible under the American Recovery and Reinvestment Act (ARRA).

29 Sep 2010

Computer simulations show low prevalence of TB increases MDR-TB risk

While the U.S. has made great progress in the prevention and treatment of tuberculosis, the nation has become more susceptible to potential epidemics of multidrug-resistant tuberculosis (MDR-TB), according a study led by Johns Hopkins researchers. Computer simulations show that as TB prevalence falls, the risk for more extensive MDR-TB increases.

28 Sep 2010

NPL, Orla receives fund to improve detection methods for TB

Two UK companies have been awarded joint funding for a research project that could see significant advances in the quest to aid detection and eradication of Tuberculosis (TB), across the world.

28 Sep 2010

Opinions: U.S. food aid; MDGs; Contraceptive access, technology; U.S. AIDS funding; Foreign assistance reform

"The best way to help the millions of hungry people in countries that receive food aid get rid of their corrupt and incompetent rulers - and to ensure that their children will never go hungry in future — is to starve them now. That will turn them into raging, unstoppable anti-government regime changers," writes Nation Media Group Executive Editor Charles Onyango-Obbo in an East African opinion piece.

28 Sep 2010

MDG summit: Funding the Global Fund; Arab world's 'own challenges'

BusinessDay reports that following last week's Millennium Development Goal summit at the U.N. in New York, advocates "have called on rich nations to double their pledges to the Global Fund to Fight AIDS, Tuberculosis and Malaria, saying it desperately needs more money if the world is to meet the health-related Millennium Development Goals by 2015."

28 Sep 2010

BMC physicians receive $3M NIH grant to identify TB biomarkers

Boston Medical Center has been chosen to lead an investigation aimed at developing novel approaches to prevent tuberculosis. Jerrold J. Ellner, MD, chief of the section of infectious diseases at BMC and professor of medicine at the Boston University School of Medicine, a renowned expert in the field, will serve as principal investigator on the five-year, $3 million grant funded by the National Institutes of Health.

28 Sep 2010

BMC physicians to lead international research collaboration to curb infectious diseases

Boston Medical Center (BMC) has been chosen to lead an investigation aimed at developing novel approaches to prevent tuberculosis (TB). Jerrold J. Ellner, MD, chief of the section of infectious diseases at BMC and professor of medicine at the Boston University School of Medicine (BUSM), a renowned expert in the field, will serve as principal investigator (PI) on the five-year, $3 million grant funded by the National Institutes of Health (NIH).

27 Sep 2010

Global leaders announce new commitments to accelerate progress towards ending malaria deaths

Prominent leaders in global health and development joined several African heads of state at UN Headquarters today to announce new commitments to accelerate progress toward ending deaths from malaria, a disease that claims the lives of more than 850,000 Africans each year.

24 Sep 2010

CGI summit looks at businesses' involvement in philanthropy

A growing number of companies are putting more emphasis on philanthropic investments, former President Bill Clinton and business leaders said on Wednesday during the second day of the Clinton Global Initiative (CGI) meeting in New York, Reuters reports.

24 Sep 2010

Past exposure to pathogens leads to disease resistance spreading through populations

A study by researchers at Royal Holloway, University of London, University College London and Oxford University, has found that a genetic variant which reduces the chance of contracting diseases such as tuberculosis and leprosy is more prevalent in populations with long histories of urban living.

24 Sep 2010

Tuberculosis News and Research

Latest Tuberculosis News and Research

Aeras Global receives FDA grant to develop biomarkers for TB vaccine

FDA awards $2.9 million to support tuberculosis research projects

Media outlets look ahead to next week's Global Fund replenishment meeting

Scientist discovers novel pathogen from Mycobacterium tuberculosis complex

GSA urges treatment of sepsis as a medical emergency

FDA grants Emergent Fast Track Designation for AVP-21D9 anthrax monoclonal antibody development program

U.N. agencies' report examines global progress in fight against HIV/AIDS

Opinions: U.S. aid to Pakistan; MDGS; GHI and Global Fund

Significant progress made universally in increasing access to HIV/AIDS services: Report

Tamir's compounds perform better than Ganciclovir for Cytomegalovirus disease: Study

NIH grants Akonni $3M for development of multi-drug resistant/extensively drug-resistant genotyping test

Computer simulations show low prevalence of TB increases MDR-TB risk

NPL, Orla receives fund to improve detection methods for TB

Opinions: U.S. food aid; MDGs; Contraceptive access, technology; U.S. AIDS funding; Foreign assistance reform

MDG summit: Funding the Global Fund; Arab world's 'own challenges'

BMC physicians receive $3M NIH grant to identify TB biomarkers

BMC physicians to lead international research collaboration to curb infectious diseases

Global leaders announce new commitments to accelerate progress towards ending malaria deaths

CGI summit looks at businesses' involvement in philanthropy

Past exposure to pathogens leads to disease resistance spreading through populations

Clue's CEO Rhiannon White on the Future of Femtech and PCOS

Freezing Point Osmometry in Life Science Applications

Precision in every drop: Inside Hamilton’s syringe technology

Tuberculosis News and Research

Latest Tuberculosis News and Research

Clue's CEO Rhiannon White on the Future of Femtech and PCOS

Freezing Point Osmometry in Life Science Applications

Precision in every drop: Inside Hamilton’s syringe technology

Newsletters you may be interested in